[1]
R. S. K and C. K.P.R, “FORMULATION DEVELOPMENT OF EFAVIRENZ TABLETS EMPLOYING Β CYCLODEXTRIN, SOLUPLUS AND PVP K30: FACTORIAL STUDY”, irjpas, vol. 3, no. 4, pp. 110-115, Aug. 2013.